†Kaplan-Meier estimates with 2-sided 95% CIs were used to describe RFS; differences between subgroups were evaluated using log-rank test.2
‡Also referred to as minimal residual disease.
ALL, acute lymphoblastic leukemia; BiTE, Bispecific T-cell Engager; CD, cluster of differentiation; CI, confidence interval; HCT, hematopoietic cell transplantation; MRD, measurable or minimal residual disease; NCCN, National Comprehensive Cancer Network; Ph(–), Philadelphia chromosome–negative; RFS, relapse-free survival.